Members only publications are marked with a lock icon:
Filter By
Clinical Alerts
May 12, 2016
The U.S. Food and Drug Administration is advising that the serious side effects associated with fluoroquinolone antibacterial drugs generally outweigh the benefits for patients with sinusitis, bronchitis, and uncomplicated urinary tract infections...
Clinical Alerts
May 10, 2016
FDA is warning that the antipsychotic medicine olanzapine can cause a rare but serious skin reaction that can progress to affect other parts of the body. FDA is adding a new warning to the drug labels for all olanzapine-containing products that...
Clinical Alerts
April 19, 2016
GENERAL PNEUMOCOCCAL VACCINATION QUESTIONS Why get vaccinated for pneumococcal disease? The most effective way to treat pneumococcal disease is to prevent it through immunization . Pneumococcal disease is a common, yet potentially serious infection...
Clinical Alerts
April 8, 2016
AUDIENCE: Pharmacy, Nephrology, Internal Medicine, Patient ISSUE: FDA is requiring labeling changes regarding the recommendations for metformin-containing medicines for diabetes to expand metformin's use in certain patients with reduced kidney...
Clinical Alerts
December 24, 2015
From: Federal Practitioner View the full article, with tables and graphics here . Federico Perez, MD; Robin L.P. Jump, MD, PhD Dr. Perez and Dr. Jump are physicians and researchers at the Louis Stokes VAMC and assistant professors of medicine at...
Clinical Alerts
April 30, 2015
Background: On August 13, 2014, the Advisory Committee on Immunization Practices (ACIP) met and approved changes to their recommendations for pneumococcal vaccination. Of note, the ACIP now recommends the routine use of 13-valent pneumococcal...